p38MAPKa stromal reprogramming sensitizes metastatic breast cancer to immunotherapy.
Faget DV, Luo X, Inkman MJ, Ren Q, Su X, Ding K, Waters MR, Raut GK, Pandey G, Dodhiawala PB, Ramalho-Oliveira R, Ye J, Cole T, Murali B, Zheleznyak A, Shokeen M, Weiss KR, Monahan JB, DeSelm CJ, Lee AV, Oesterreich S, Weilbaecher KN, Zhang J, DeNardo DG, Stewart SA.
Faget DV, et al. Among authors: dodhiawala pb.
Cancer Discov. 2023 Mar 8:CD-22-0907. doi: 10.1158/2159-8290.CD-22-0907. Online ahead of print.
Cancer Discov. 2023.
PMID: 36883955